ISSN: 2459 - 1777 | E-ISSN 2587-0394
Volume: 4
Issue: 2
Year: 2019
Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid [Beyoglu Eye J]
Beyoglu Eye J. 2017; 2(1): 29-32 | DOI: 10.14744/bej.2017.68077  

Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid

Gamze Ozturk Karabulut, Korhan Fazil, Can Ozturker, Berna Basarir, Muhittin Taskapili, Pelin Kaynak
University of Health Sciences Beyoglu Eye Training and Research Hospital, Istanbul, Turkey

A 61-year-old male presented with 20 x 15 mm diffuse, hyperpigmented lesion that covered the right upper eyelid and which had been present for 2 years. Lesion was diagnosed as actinic keratosis (AK). Since the patient refused surgery and reconstruction, he was treated with imiquimod (IMQ) 5% cream once a day, 5 times per week for 6 weeks. Lesion gradually reduced in size and no clinically evident residual keratosis was observed after treatment. No post-therapy excision was performed to assess histological clearance of AK for cosmetic reasons. Although surgery is first-line treatment for these lesions, in case of refusal to undergo surgery, when lesion is superficial and diffuse and in region where reconstruction would be difficult, treatment with IMQ may be preferred.

Keywords: Actinic keratosis, Aldara, imiquimod.


Gamze Ozturk Karabulut, Korhan Fazil, Can Ozturker, Berna Basarir, Muhittin Taskapili, Pelin Kaynak. Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid. Beyoglu Eye J. 2017; 2(1): 29-32

Corresponding Author: Gamze Ozturk Karabulut, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




Copyright © 2019 Beyoglu Eye Journal LookUs & Online Makale